{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:20:38Z","timestamp":1772752838410,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jbiotec.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:45:27Z","timestamp":1752680727000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of a novel virus-like particle platform to the development of Neisseria vaccines"],"prefix":"10.1016","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-8792","authenticated-orcid":false,"given":"Laura Burgess","family":"Tornaletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1294-175X","authenticated-orcid":false,"given":"Aljawharah Fahad","family":"Alabbad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Thistlethwaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0411-8774","authenticated-orcid":false,"given":"Smruti","family":"Rashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4350-5354","authenticated-orcid":false,"given":"Jeremy P.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2025.07.012_bib1","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.vaccine.2020.03.001","article-title":"An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis","volume":"38","author":"Aston-Deaville","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2025.07.012_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","article-title":"Efficacy trial of a parenteral gonococcal pilus vaccine in men","volume":"9","author":"Boslego","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2025.07.012_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1462-5822.2001.00092.x","article-title":"Expression, activity and cytotoxicity of pertussis toxin S1 subunit in transfected mammalian cells","volume":"3","author":"Castro","year":"2001","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib4","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1016\/j.vaccine.2016.09.042","article-title":"Manufacturing costs of HPV vaccines for developing countries","volume":"34","author":"Clendinen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2025.07.012_bib5","doi-asserted-by":"crossref","first-page":"731845","DOI":"10.3389\/fimmu.2021.731845","article-title":"Superantigen recognition and interactions: functions, mechanisms and applications","volume":"12","author":"Deacy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib6","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106228","article-title":"Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic review","volume":"89","author":"Griskaitis","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2019.00592","article-title":"Immunogenicity of a virus-like-particle vaccine containing multiple antigenic epitopes of toxoplasma gondii against acute and chronic toxoplasmosis in mice","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.96.5.1915","article-title":"Native display of complete foreign protein domains on the surface of hepatitis B virus capsids","volume":"96","author":"Kratz","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib10","doi-asserted-by":"crossref","first-page":"12360","DOI":"10.1073\/pnas.1510533112","article-title":"Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery","volume":"112","author":"Lu","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00245-23","article-title":"Development of a Tag\/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme","volume":"91","author":"Martinez","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib13","article-title":"Hepatitis B core-based virus-like particles: a platform for vaccine development in plants","volume":"29","author":"Moradi Vahdat","year":"2021","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.meegid.2016.01.027","article-title":"Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine","volume":"39","author":"Mosavat","year":"2016","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fpls.2019.00455","article-title":"Epitope presentation of dengue viral envelope glycoprotein domain III on hepatitis B core protein virus-like particles produced in nicotiana benthamiana","volume":"10","author":"Pang","year":"2019","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jbiotec.2025.07.012_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.copbio.2021.05.001","article-title":"Molecular characterization of HEK293 cells as emerging versatile cell factories","volume":"71","author":"Pulix","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.193.3.281","article-title":"Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae","volume":"193","author":"Ram","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib19","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2020.10.077","article-title":"A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection","volume":"38","author":"Sikora","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jbiotec.2025.07.012_bib20","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1038\/s41467-024-51053-x","article-title":"Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population","volume":"15","author":"Stejskal","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib21","doi-asserted-by":"crossref","first-page":"796991","DOI":"10.3389\/fbioe.2021.796991","article-title":"HEK293 cell line as a platform to produce recombinant proteins and viral vectors","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","article-title":"Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbiotec.2025.07.012_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00094-23","article-title":"Neisseria gonorrhoeae vaccines: a contemporary overview","author":"Williams","year":"2024","journal-title":"Clin. Microbiol Rev., e0009423"},{"issue":"4","key":"10.1016\/j.jbiotec.2025.07.012_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/vaccines7040153","article-title":"Integrated Bioinformatic Analyses and Immune Characterization of New Neisseria gonorrhoeae Vaccine Antigens Expressed during Natural Mucosal Infection","volume":"7","author":"Zhu","year":"2019","journal-title":"Vaccines"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165625001828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165625001828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:42:37Z","timestamp":1772750557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165625001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"alternative-id":["S0168165625001828"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2025.07.012","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a novel virus-like particle platform to the development of Neisseria vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}